Trial Profile
Phase II study of TS-1 in elderly patients with unresectable non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2012
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 18 Jun 2012 Actual end date (Dec 2009) added as reported by University Hospital Medical Information Network - Japan.
- 18 Jun 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 08 Jun 2009 New trial record.